Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Research and Markets - United States $15 Billion Proton Therapy Market, 2021 Featuring Elekta, IBA & Varian

This image opens in the lightbox

News provided by

Research and Markets

10 Apr, 2017, 15:00 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, Apr. 10, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report to their offering.

The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future.

At present the United States holds world's 40 percent of Proton Beam Therapy Facility. In recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.

In this report we have studied the market in two parts: a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

Key Companies Covered:

- IBA (Overview, Sales Analysis)

- Varian Medical Systems (Overview, Sales Analysis)

- Elekta (Overview, Sales Analysis)

Key Topics Covered:

1. Executive Summary

2. United States Proton Therapy Market - Actual & Potential Market

    2.1 United States - Proton Therapy Market

    2.2 United States - Potential Proton Therapy Market & Forecast

3. United States Proton Therapy Patient Number - Actual and Potential

    3.1 United States - Patients Treated with Proton Therapy Actual Numbers & Forecast

    3.2 United States - Patients with Proton Therapy Potential Numbers & Forecast

4. United States - List of Proton Therapy Centers

5. United States - Proton Therapy Treated Patients by Centers

    5.1 Loma Linda (LLUMC) Proton Therapy Center - Number of Patients Treated (2008 - 2014)

    5.2 UCSF - CNL Proton Therapy Center - Number of Patients Treated (2008 - 2015)

    5.3 Boston (NPTC) Proton Therapy Center - Number of Patients Treated (2008 - 2015)

    5.4 Bloomington (MPRI, 2) Proton Therapy Center - Number of Patients Treated (2008 - 2014)

    5.5 Houston (MD Anderson) Proton Therapy Center - Number of Patients Treated (2008 - 2015)

    5.6 UFPTI Jacksonville Proton Therapy Center - Number of Patients Treated (2008 - 2015)

    5.7 Oklahoma City (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2009 - 2015)

    5.8 CDH Warrenville Proton Therapy Center - Number of Patients Treated (2010 - 2015)

    5.9 Philadelphia (Upenn) Proton Therapy Center - Number of Patients Treated (2011 - 2015)

    5.10 Hampton (HUPTI) Proton Therapy Center - Number of Patients Treated (2012 - 2015)

    5.11 New Jersey (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2012 - 2015)

    5.12 Seattle (SCCA ProCure PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)

    5.13 St. Louis (S. Lee King PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)

    5.14 Provision Center for Proton Therapy, Knoxville, TN - Number of Patients Treated (2014 - 2015)

    5.15 San Diego (Scripps PTC) - Number of Patients Treated (2014 - 2015)

    5.16 Shreveport (Willis Knighton) Proton Therapy Center - Number of Patients Treated (2014 - 2015)

    5.17 Jacksonville (Ackerman CC) Proton Therapy Center - Number of Patients Treated (2015)

    5.18 Rochester (Mayo PBTC) Proton Therapy Center - Number of Patients Treated (2015)

    5.19 Brunswick (Laurie PC) Proton Therapy Center - Number of Patients Treated (2015)

    5.20 Irving (Texas Center for PT) Proton Therapy Center - Number of Patients Treated (2015)

    5.21 Memphis (St. Jude PTC) Proton Therapy Center - Number of Patients Treated (2015)

6. Proton Therapy - Reimbursement Policies

    6.1 Proton Therapy Reimbursement Policies for Patients

    6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7. Components of a Standard Proton Therapy Center

    7.1 Proton Accelerator

        7.1.1 Synchrotrons (example: LLUMC at Loma Linda)

        7.1.2 Cyclotrons (example: MGH Boston)

        7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)

        7.1.4 Linacs (Rome)

        7.1.5 H-minus Synchrotrons

        7.1.6 Separated Sector Cyclotrons

        7.1.7 Super-conducting Cyclotrons

        7.1.8 Fast Cycling Synchrotron

    7.2 Beam Transport System

    7.3 Beam Delivery System

        7.3.1 The Passive Scattering Technique

        7.3.2 Beam Scanning

    7.4 Nozzle

        7.4.1 Single Scattering

        7.4.2 Double Scattering

        7.4.3 Uniform Scanning Nozzle

        7.4.4 Pencil Scanning Nozzle

    7.5 Treatment Planning System

    7.6 Image Viewers

    7.7 Patient Positioning System (PPS)

    7.8 Human Resource

8. Global Proton Therapy - Company Analysis (2010-2021)

    8.1 IBA Proton Therapy

        8.1.1 Sales Analysis

    8.2 Varian Medical Systems

        8.2.1 Sales Analysis

    8.3 Elekta

        8.3.1 Sales Analysis

9. Proton Therapy - Driving Factors

    9.1 Technology Advancement

    9.2 Growing Incidence of Cancer Patients in United States

10. Proton Therapy - Challenges

    10.1 Requires Huge Investment

    10.2 Operations Challenges

For more information about this report visit

http://www.researchandmarkets.com/research/38mcvc/united_states

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.